Apabetalone (RVX-208) may lower CVD events in diabetes...

Atherosclerosis 2017 / 08 Vol. 263

Apabetalone (RVX-208) may lower CVD events in diabetes mellitus by affecting complement pathway and microbiome activity

Kulikowski, Ewelina, Calosing, Cyrus, Tsujikawa, Laura, Wasiak, Sylwia, Gilham, Dean, Halliday, Christopher, Johansson, Jan, Sweeney, Michael, Wong, Norman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
263
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2017.06.363
Date:
August, 2017
File:
PDF, 49 KB
english, 2017
Conversion to is in progress
Conversion to is failed